Figure 5.

Changes in modified Sharp score in patients with active rheumatoid arthritis despite methotrexate (MTX) therapy who were given MTX alone or in combination with infliximab (the Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis With Concomitant Therapy [ATTRACT] study) [39–41].

Schwartzman et al. Arthritis Res Ther 2004 6(Suppl 2):S3-S11   doi:10.1186/ar1013